Back to top

Oncopeptides AB Reports Strong Q1 2025 Growth and Strategic Advances

An update from Oncopeptides AB ( ($SE:ONCO) ) is now available. Oncopeptides AB reported a significant 161% increase in net sales in Q1 2025 compar...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Onconetix, Inc. (ONCO)

ProShares On-Demand ETF (OND)